Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Eskilstuna

14 clinical trials in Eskilstuna, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Eskilstuna at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Eskilstuna

Open in trial search

Study of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Eli Lilly & Co.

A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.

Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Uppsala Universitet

Study of personalized tamoxifen dosing (10mg, 20mg, or 40mg daily) compared to standard dose (20mg) in women with breast cancer to improve treatment continuation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen
  • Sponsor:Karolinska Institutet

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Breast cancer

Recruiting

Study on Extended Endocrine Therapy for High-Risk Breast Cancer Patients Using Tamoxifen, Exemestane, Anastrozole, and Letrozole

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Region Oerebro Laen

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karolinska University Hospital

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Skane

Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mannitol
  • Sponsor:Region Stockholm – SLSO

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Eskilstuna

What the registry says about research in the country

01 Cardiovascular and Neurological Studies

Innovative research exploring treatments for acute ischemic stroke, with trials testing new therapeutic approaches within critical time windows. Studies also examine stroke prevention in patients with atrial fibrillation and chronic kidney disease.

  • Stroke Treatment Development
  • Cardiovascular Prevention
  • Renal Complications

Focused on improving patient outcomes through targeted interventions and preventive strategies.

02 Oncology Research

Comprehensive studies in breast cancer treatment optimization, including hormone therapy strategies and targeted treatments for HER2-positive cases. Additional research covers glioblastoma and melanoma management.

  • Advanced Breast Cancer Therapies
  • Brain Cancer Treatment
  • Immunotherapy Applications

Evaluating innovative treatment approaches for various cancer types and stages.

03 Surgical and Infectious Disease Studies

Investigation of infection prevention in hip arthroplasty procedures and research on treating resistant urinary tract infections. Studies focus on improving surgical outcomes and addressing antimicrobial resistance.

  • Surgical Innovation
  • Infection Control
  • Antibiotic Resistance

Developing effective strategies against surgical complications and resistant infections.

04 Women's Health and Obstetrics

Clinical research examining labor induction methods, comparing outpatient versus inpatient approaches to enhance maternal care and outcomes.

  • Labor Management
  • Patient Care Settings
  • Maternal Safety

Focused on optimizing childbirth experiences while maintaining safety standards.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.